Debra Diz to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Debra Diz has written about Drug Evaluation, Preclinical.
Connection Strength
0.021
-
Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, Wheeler KT, Olson J, Zhao W. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):499-505.
Score: 0.021